About Aisap
AISAP is a pioneering healthcare AI company that develops AI-powered Point-of-Care Assisted Diagnosis (POCAD™) solutions, primarily focusing on medical ultrasound. Their flagship product, AISAP CARDIO, is the world’s first real-time AI-powered cardiac diagnostic platform. This technology is designed to empower clinicians with immediate and highly accurate diagnostics for structural heart diseases and heart failure directly at the patient’s bedside.
The AISAP platform streamlines ultrasound workflows and provides AI-driven interpretations by utilizing deep convolutional neural networks to analyze ultrasound images in real-time. This enables medical professionals, including emergency medicine, critical care, internal medicine, hospitalists, and primary care physicians, to make informed care decisions quickly, even with basic scanning skills. The company’s technology has been validated on thousands of patients, demonstrating high accuracy and leading to changes in clinical management for a significant portion of scanned patients, resulting in earlier discharge and optimized treatment plans. AISAP’s mission is to democratize medical diagnostics and advance health equity through AI, particularly in underserved regions.
Focus Areas
Business Intelligence
| Technology | Cloud-based platform (POCAD) leveraging deep learning AI for real-time analysis of ultrasound images and data. |
What Physicians Need to Know
For physicians, AISAP's technology offers the ability to perform fast, accurate, and comprehensive cardiac diagnostics directly at the patient's bedside, regardless of their sonography experience. This can lead to earlier detection and treatment of critical cardiac conditions like structural heart disease and heart failure, potentially improving patient outcomes and reducing healthcare costs. The platform provides objective, clinically relevant cardiac and valvular measurements, increasing confidence and expanding the role of cardiac ultrasound in everyday clinical practice. It also streamlines workflows by automating image acquisition, interpretation, and report generation, freeing up time for more acute cases.
AISAP's POCUS OS is designed as a vendor-agnostic solution, integrating seamlessly with any point-of-care ultrasound device, existing EHR/EMR, and PACS systems. It offers a secure 'on-premise to cloud' architecture for flexible deployment and reliable imaging storage.
What the Web Says
AISAP is a company focused on AI-powered point-of-care ultrasound (POCUS) for cardiac diagnostics, with its flagship product being AISAP CARDIO. The platform aims to empower clinicians with varying scanning skills to accurately diagnose common cardiac conditions, streamline diagnosis, and improve patient outcomes. While there are many positive reviews regarding the product's effectiveness and impact on patient care, information on company culture and employer reviews is limited.
Overall: PositiveStrengths
- User-friendly interface designed for clinicians.
- Provides comprehensive and accurate cardiac assessments, including valvular pathology and LVEF.
- Improves clinician accuracy in interpreting point-of-care echocardiograms.
- Seamless integration with existing EHR/EMR and PACS systems.
- Enhances clinical efficiency, speed, and decision-making at the point of care.
- FDA-cleared cardiac algorithms with high accuracy in detecting major valve diseases.
Limitations
- Requires a stable internet connection for cloud-based features.
- New users may need training to fully leverage advanced features.
- Optimal performance depends on compatibility with ultrasound hardware.
- Potential for AI algorithm bias if training data is uniform or healthcare procedures are unfair.
- Implementation can be costly.
- Limited public information on company/employer reviews across major platforms.
Based on reviews from: Aisap.ai, Indeed.com, Healthcare Industry Reviews, G2, YouTube, TenereTeam.com, Daily CSR, TrustRadius
Last updated: 2026-10-17
Videos
News, demos, and interviews about Aisap.
Videos load interactively. If none appear, search YouTube for Aisap →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]
Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]
Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]
Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]
HeartLung.AI is a health-tech company focused on leveraging artificial intelligence for the early detection and prevention of cardiovascular disease and lung cancer. Their mission is to shift healthcare from late-stage disease treatment to earlier identification and prevention by unlocking clinically actionable information embedded within routine medical imaging. The company has developed several FDA-cleared and breakthrough-designated […]
Heartvue.ai is a healthcare AI company focused on transforming cardiovascular imaging analysis. Founded by a cardiologist with over two decades of experience in advanced cardiac imaging, the company develops AI-powered tools to make advanced cardiac imaging analysis more accessible, consistent, and efficient for healthcare systems. Their mission is to alleviate the burden of manual workflows […]